News

The research paper, “APOLLOE4 Phase 3 Study of Oral ALZ-801/Valiltramiprosate in APOE ε4/ε4 Homozygotes with Early Alzheimer’s Disease: Trial Design & Baseline Characteristics,” was ...
“In this publication, we review the limitations ... consider the complex AD pathophysiology and incorporate novel study design elements. Taken together, these factors support the advancement ...
This outcome provides an added measure of impact and adds to the strength of the study design. Read the full publication here: Randomized Placebo-Controlled Trial of 60-Day Percutaneous Peripheral ...